Mangoceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MGRX | LFMD | CANF | COSM | TXMD | RX.V | |
|---|---|---|---|---|---|---|
| Market cap | 4.60M | 118.23M | 5.06M | 32.97M | 21.07M | 192.63M |
| P/E (TTM) | — | — | — | — | — | 20.2 |
| Forward P/E | — | 6.4 | -1.8 | 4.7 | 5.2 | 30.6 |
| Price/book | 0.3 | 14.7 | 0.7 | 1.3 | 0.8 | 4.2 |
| Dividend yield | — | — | — | — | — | 1.28% |
| 1-year change | −88.75% | −61.28% | −80.12% | −51.26% | +43.31% | +59.24% |
| Today | −5.00% | +12.39% | +3.02% | +7.73% | +2.25% | +1.78% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 15 min.
Latest news
All MGRX news ›Reviewing Mangoceuticals (NASDAQ:MGRX) & Getinge (OTCMKTS:GNGBY)
Posted by Kim Johansen on Oct 20th, 2026 Mangoceuticals (NASDAQ:MGRX – Get Free Report) and Getinge (OTCMKTS:GNGBY – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies…
Critical Comparison: Mangoceuticals (NASDAQ:MGRX) & Quest Diagnostics (NYSE:DGX)
Posted by Sarita Garza on Oct 13th, 2026 Mangoceuticals (NASDAQ:MGRX – Get Free Report) and Quest Diagnostics (NYSE:DGX – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
The Manila Times Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to s
Mangoceuticals Raises $492,750 in Registered Direct Offering of Shares and Warrants
TradingView Mangoceuticals Raises $492,750 in Registered Direct Offering of Shares and Warrants Mangoceuticals entered into a securities purchase agreement for a registered direct offering to raise approximately $49
Mangoceuticals CEO Cohen reports 21.5% ownership stake
With 1.63M option shares included, Mangoceuticals (MGRX) CEO reports his ownership stake. Stock Titan - [SCHEDULE 13D/A] MANGOCEUTICALS, INC. Amended Major Shareholder Report Mangoceuticals CEO Cohen reports 21.5% ownership stake Cohen…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- manilatimes.net2
- stocktitan.net2
- themarketsdaily.com2
- globenewswire.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.